Leef Brands LEEEF
OTC LEEEF
$0.20 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026)

Leef Brands (LEEEF) posted Total Non-Current Liabilities of $36.1 million for Q1 2026, up 0.86% sequentially from $35.8 million in Q4 2025.

Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends

Leef Brands has reported Total Non-Current Liabilities for 4 years, with the latest figure at $36.1 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $36.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.1 million (changed N/A YoY) and the FY2025 annual result came in at $35.8 million, down 22.9% from the prior year.
  • Total Non-Current Liabilities rose to $36.1 million in Q1 2026 per LEEEF's latest filing, from $35.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $46.4 million in Q4 2024 and troughed at -$1.1 million in Q4 2023.
  • A 4-year average of $29.3 million and a median of $35.9 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities soared 4340.37% in 2024, then decreased 22.9% in 2025.
  • Over 4 years, Total Non-Current Liabilities stood at -$1.1 million in 2023, then jumped by 4340.37% to $46.4 million in 2024, then slipped by 22.9% to $35.8 million in 2025, then climbed by 0.86% to $36.1 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $36.1 million, $35.8 million, and $46.4 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 334.00 Mn
10 Leef Brands 59.45 Mn 54.50 Mn 2.41 Mn 41.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 41.92 Mn
Mar 31, 2026 36.08 Mn
Dec 31, 2025 35.78 Mn
Dec 31, 2024 46.40 Mn
Dec 31, 2023 -1.09 Mn